Hims & Hers director exercises 15,211 RSUs

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director Christiane Pendarvis exercised previously granted restricted stock units, converting 15,211 RSUs into the same number of Class A common shares at a price of $0.00 per share, reflecting equity compensation rather than an open-market purchase.

The RSUs vest over three years, with one-third vesting on March 15, 2024, one-third on March 15, 2025, and one-third on March 15, 2026. Following this conversion, Pendarvis directly holds 51,774 Class A shares, and the filing shows no sales or tax-withholding disposals, indicating a straightforward exercise-and-hold event.

Insider Trade Summary

15,211 shares exercised/converted

Exercise 2 txns

Insider Pendarvis Christiane

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	15,211	$0.00	$0.00
Exercise	Class A Common Stock	15,211	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Class A Common Stock — 51,774 shares (Direct)

Footnotes (2)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on March 15, 2024, (ii) 1/3 of the RSUs vesting on March 15, 2025, and (iii) 1/3 of the RSUs vesting on March 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hims & Hers (HIMS) report for Christiane Pendarvis?

Hims & Hers reported that director Christiane Pendarvis exercised 15,211 restricted stock units into Class A common stock. This was an equity compensation event with no open-market buying or selling, simply converting vested RSUs into directly held shares.

How many Hims & Hers (HIMS) shares does Christiane Pendarvis hold after this Form 4?

After the RSU conversion, Christiane Pendarvis directly holds 51,774 shares of Hims & Hers Class A common stock. This figure reflects her post-transaction position as reported, with no indication of simultaneous share sales or tax-withholding dispositions.

Were the Hims & Hers (HIMS) RSUs for Christiane Pendarvis tied to a vesting schedule?

Yes. The restricted stock units vest over three years: one-third on March 15, 2024, another third on March 15, 2025, and the final third on March 15, 2026. Each vested RSU entitles her to receive one share of Class A common stock.

Did Christiane Pendarvis buy or sell Hims & Hers (HIMS) shares on the open market?

No open-market purchases or sales are shown. The Form 4 records an exercise of 15,211 RSUs into Class A shares at a price of $0.00 per share, a standard equity compensation conversion without reported market trading activity.

What does the $0.00 price on the Hims & Hers (HIMS) RSU exercise mean?

The $0.00 price indicates these shares were received through restricted stock units rather than bought for cash in the market. Each RSU converted into one share of Class A common stock as part of Pendarvis’s compensation package and associated vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pendarvis Christiane

(Last) (First) (Middle)

2269 CHESTNUT ST., #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/13/2026		M		15,211	A	(1)	51,774	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/13/2026		M			15,211	(2)	(2)	Class A Common Stock	15,211	$0	0	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on March 15, 2024, (ii) 1/3 of the RSUs vesting on March 15, 2025, and (iii) 1/3 of the RSUs vesting on March 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Christiane Pendarvis	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.